Literature DB >> 32081700

What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?

Yusha Chen1, Sushmita Pradhan1, Siliang Xue2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32081700      PMCID: PMC7134506          DOI: 10.1016/j.jaad.2020.02.030

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
In late December 2019, several individuals with unexplained pneumonia were reported in Wuhan, China. A novel coronavirus was subsequently identified as the causative pathogen and provisionally designated 2019 novel coronavirus (2019-nCoV). As of February 10, 2020, 42,638 cases of 2019-nCoV infection have been confirmed in China, with 21,675 suspected cases and 1016 deaths. There are still more than 3000 confirmed cases every day, involving people living in or visiting Wuhan, as a subsequent characteristic of human-to-human transmission. 2019-nCoV continues to spread around the world and has been reported in other countries such as the United States. Hospitals in all provinces and cities across China have taken effective measures to control the spread of 2019-nCoV. On January 24, 2020, the West China Hospital of Sichuan University temporarily shut the doors of its dermatology outpatient department and dermatology surgery by postponing all of the elective operations and limiting to only emergency operations. We did not, however, completely halt the services to some patients who need to visit the dermatology outpatient department during the 2019-nCoV outbreak. At the same time, to meet the medical requirements and reduce the flow of patients to the skin clinic, we began free online and telephone consultation by providing free dermatology consultations. The dermatology outpatient department in West China Hospital was scheduled to run on January 28, 2020, mainly for critical care patients. Patients who had made an advanced appointment for obtaining medical service but chose not to visit received a full refund of registration fees. The number of dermatology outpatient clinics has been drastically reduced from 8 to 4, and only 1 accompanying person is allowed to enter the clinic. People entering the outpatient and inpatient buildings must wear masks and have their body temperature monitored by professionals wearing tight protective clothing. At the entrance of the building, anyone with a fever (body temperature ≥37.3°C), travel history to Wuhan in last 2 weeks, clear contact with residents in Wuhan in last 2 weeks, or contact with people with a fever would be directly sent to the fever clinic for screening. These individuals are considered to have been exposed and are quarantined for 2 weeks, and potential exposures are also asked to quarantine themselves for 2 weeks at home. During the skin clinic, patients are not allowed to take off their masks except on indications of facial lesions. Doctors must wear masks, surgical caps, protective suits, gloves, and goggles at work; they take off their protective equipment only after their work in a designated disposable area. In other respects, educational programs and activities of West China Hospital have come to a halt; graduate students and interns are prohibited from returning to school and work. Also, West China Hospital established special psychologic intervention counseling via a telephone and network platform to help those in need and published a psychologic protection handbook for free download. It is uncertain to predict when the 2019-nCoV will end at the time of this writing. The West China hospital is still playing a powerful role in defending against the epidemic outbreak and is a microcosm of all of the countless Chinese hospitals at this moment.
  2 in total

1.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

2.  First Case of 2019 Novel Coronavirus in the United States.

Authors:  Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai
Journal:  N Engl J Med       Date:  2020-01-31       Impact factor: 91.245

  2 in total
  37 in total

Review 1.  Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms.

Authors:  F González González; C Cortés Correa; E Peñaranda Contreras
Journal:  Actas Dermosifiliogr       Date:  2021-01-28

2.  Continuing patient care to underserved communities and medical education during the COVID-19 pandemic through a teledermatology student-run clinic.

Authors:  Danny Linggonegoro; Renajd Rrapi; Sepideh Ashrafzadeh; Lindsay McCormack; Diana Bartenstein; T J Hazen; Abigail Kempf; Eun Jae Kim; Kevin Moore; Xavier Sanchez-Flores; Hannah Song; Jennifer T Huang; Sadaf Hussain
Journal:  Pediatr Dermatol       Date:  2021-06-07       Impact factor: 1.997

3.  Cancer Care During COVID-19 Era: The Quality of Life of Patients With Thyroid Malignancies.

Authors:  Rosa Falcone; Giorgio Grani; Valeria Ramundo; Rossella Melcarne; Laura Giacomelli; Sebastiano Filetti; Cosimo Durante
Journal:  Front Oncol       Date:  2020-06-23       Impact factor: 6.244

4.  Resuming work gradually in the context of COVID-19: Experience from a tertiary dermatology department in China.

Authors:  Keyun Tang; Hanlin Zhang; Hongzhong Jin
Journal:  Dermatol Ther       Date:  2020-06-15       Impact factor: 3.858

5.  Safety measures in dermatology help minimize spread of COVID-19.

Authors:  Andy Goren; Dipali Rathod; George Kroumpouzos; Mohammad Jafferany; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-07-07       Impact factor: 3.858

6.  Safety guidelines for nonsurgical facial procedures during COVID-19 outbreak.

Authors:  Dario Bertossi; Ash Mohsahebi; Wolfgang G Philipp-Dormston; Izolda Heidenrich; Ali Pirayesh; Alwyn D'Souza; Hesham Saleh; Rezha Yavuzer; Nabil Fakih; Julia Vent; Eqram Rahman; Krishan Mohan Kapoor
Journal:  J Cosmet Dermatol       Date:  2020-07-01       Impact factor: 2.189

7.  Update on COVID-19 effects in dermatology specialty.

Authors:  Mohamad Goldust; George Kroumpouzos; Dedee F Murrell; Lidia Rudnicka; Anupam Das; Torello Lotti; Alexander A Navarini
Journal:  Dermatol Ther       Date:  2020-06-26       Impact factor: 3.858

8.  The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review.

Authors:  Milad Haghani; Michiel C J Bliemer; Floris Goerlandt; Jie Li
Journal:  Saf Sci       Date:  2020-05-07       Impact factor: 6.392

9.  Did Whatsapp® reveal a new cutaneous COVID-19 manifestation?

Authors:  T A Duong; C Velter; M Rybojad; C Comte; M Bagot; L Sulimovic; J D Bouaziz
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-19       Impact factor: 6.166

Review 10.  COVID-19 Pandemic: Consensus guidelines for preferred practices in an aesthetic clinic.

Authors:  Krishan M Kapoor; Vandana Chatrath; Sarah G Boxley; Iman Nurlin; Philippe Snozzi; Nestor Demosthenous; Victoria Belo; Wai M Chan; Nicole Kanaris; Puneet Kapoor
Journal:  Dermatol Ther       Date:  2020-06-13       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.